Treasure Ji Pharmaceutical-B: KJ101 new indications obtained clinical trial approval

Baoji Pharmaceutical Company B announced that its independently developed and leading recombinant human mucinase enzyme KJ101, developed through synthetic biology, has been approved by the China National Medical Products Administration for clinical trials in China to dissolve and remove gastric mucosa during gastroscopy.